Charles Schwab’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,509
| Closed | -$23K | – | 3725 |
|
|
2022
Q1 | $23K | Hold |
4,509
| – | – | ﹤0.01% | 3574 |
|
|
2021
Q4 | $26K | Hold |
4,509
| – | – | ﹤0.01% | 3570 |
|
|
2021
Q3 | $50K | Hold |
4,509
| – | – | ﹤0.01% | 3451 |
|
|
2021
Q2 | $77K | Sell |
4,509
-8,568
| -66% | -$146K | ﹤0.01% | 3313 |
|
|
2021
Q1 | $344K | Sell |
13,077
-454
| -3% | -$11.9K | ﹤0.01% | 3207 |
|
|
2020
Q4 | $490K | Hold |
13,531
| – | – | ﹤0.01% | 2999 |
|
|
2020
Q3 | $480K | Buy |
13,531
+6,447
| +91% | +$229K | ﹤0.01% | 2883 |
|
|
2020
Q2 | $301K | Buy |
7,084
+5,122
| +261% | +$218K | ﹤0.01% | 3045 |
|
|
2020
Q1 | $157K | Hold |
1,962
| – | – | ﹤0.01% | 3055 |
|
|
2019
Q4 | $182K | Hold |
1,962
| – | – | ﹤0.01% | 3050 |
|
|
2019
Q3 | $149K | Sell |
1,962
-1,005
| -34% | -$76.3K | ﹤0.01% | 3074 |
|
|
2019
Q2 | $296K | Buy |
+2,967
| New | +$296K | ﹤0.01% | 3007 |
|